ARTES Biotechnology GmbH

ARTES Biotechnology GmbH is a globally active R&D company specializing in developing biopharmaceutical production processes. Since 2002, ARTES Biotechnology has been a valued partner for the pharmaceutical industry, offering proprietary expression systems and comprehensive competence from cell line development to manufacturing. With several successful technology transfers implemented worldwide at client sites, ARTES Biotechnology GmbH has established a strong reputation for excellence.

ARTES Biotechnology GmbH continues to be a robust and reliable partner, dedicated to customer-driven projects, including the supply of pre-clinical material. Furthermore, ARTES Biotechnology is actively developing its own virus-like particle (VLP) based vaccine candidates, advancing them to proof-of-concept in animals. The primary address of ARTES Biotechnology GmbH is Elisabeth-Selbert-Str. 9, Langenfeld, 40764, DE.

ARTES Biotechnology GmbH is committed to innovation and quality, ensuring that its biopharmaceutical solutions meet the highest industry standards. Information about ARTES Biotechnology GmbH will be completed soon with the support of the company’s management. We invite the manager of ARTES Biotechnology GmbH to create a customized and exclusive company showcase and product listing on our platform.